NZ208338A - Stabilisation of anthralin compositions by uncorporation of acid-stable anionic surfactant - Google Patents

Stabilisation of anthralin compositions by uncorporation of acid-stable anionic surfactant

Info

Publication number
NZ208338A
NZ208338A NZ208338A NZ20833884A NZ208338A NZ 208338 A NZ208338 A NZ 208338A NZ 208338 A NZ208338 A NZ 208338A NZ 20833884 A NZ20833884 A NZ 20833884A NZ 208338 A NZ208338 A NZ 208338A
Authority
NZ
New Zealand
Prior art keywords
weight
anthralin
composition
composition according
alkyl
Prior art date
Application number
NZ208338A
Other languages
English (en)
Inventor
J C T Wang
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NZ208338A publication Critical patent/NZ208338A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NZ208338A 1983-06-09 1984-05-31 Stabilisation of anthralin compositions by uncorporation of acid-stable anionic surfactant NZ208338A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50285283A 1983-06-09 1983-06-09

Publications (1)

Publication Number Publication Date
NZ208338A true NZ208338A (en) 1987-11-27

Family

ID=23999686

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ208338A NZ208338A (en) 1983-06-09 1984-05-31 Stabilisation of anthralin compositions by uncorporation of acid-stable anionic surfactant

Country Status (21)

Country Link
JP (1) JPS608222A (it)
AT (1) AT393959B (it)
AU (1) AU569085B2 (it)
BE (1) BE899874A (it)
CH (1) CH659945A5 (it)
CY (1) CY1531A (it)
DE (1) DE3421510A1 (it)
DK (1) DK163028C (it)
ES (1) ES8707107A1 (it)
FI (1) FI83837C (it)
FR (1) FR2547725B1 (it)
GB (1) GB2142534B (it)
HK (1) HK66490A (it)
IE (1) IE57562B1 (it)
IT (1) IT1183058B (it)
LU (1) LU85411A1 (it)
NO (1) NO171623C (it)
NZ (1) NZ208338A (it)
OA (1) OA07720A (it)
PT (1) PT78713A (it)
SE (1) SE465205B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551480A (en) * 1983-06-21 1985-11-05 Stiefel Laboratories, Inc. Compositions for the treatment of psoriasis
DE3413569A1 (de) * 1984-04-11 1985-10-24 Röhm Pharma GmbH, 6108 Weiterstadt Pharmazeutisches mittel zur psoriasis-therapie
GB8729855D0 (en) * 1987-12-22 1988-02-03 Drythanol Ltd New dithranol compositions
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070949A (en) * 1964-10-16 1967-06-07 Hyman Yarrow Topical compositions for the treatment of psoriasis
GB1574090A (en) * 1977-07-06 1980-09-03 Drythanol Ltd Dithranol composition for the treatment of psoriasis
DE3008805A1 (de) * 1980-03-07 1981-09-24 Paul 8501 Oberasbach Unger Skibremse
CA1179271A (fr) * 1981-10-23 1984-12-11 Jean-Francois Grollier Composition epaissie anhydre, stable a l'oxydation, a base d'anthraline ou de l'un de ses derives dans un support constitue d'un alkyl ester d'acide gras et d'un agent epaississant, et son utilisation dans le traitement des maladies de la peau
FR2520233A1 (fr) * 1982-01-28 1983-07-29 Oreal Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau
FR2526321A1 (fr) * 1982-05-10 1983-11-10 Salomon & Fils F Frein de ski

Also Published As

Publication number Publication date
IE57562B1 (en) 1992-12-16
AU2923784A (en) 1984-12-13
DK283884D0 (da) 1984-06-08
IT1183058B (it) 1987-10-05
AT393959B (de) 1992-01-10
FI842274A (fi) 1984-12-10
FR2547725A1 (fr) 1984-12-28
CY1531A (en) 1990-11-16
HK66490A (en) 1990-08-31
DK163028B (da) 1992-01-13
ES533186A0 (es) 1987-07-16
NO842326L (no) 1984-12-10
SE465205B (sv) 1991-08-12
NO171623B (no) 1993-01-04
NO171623C (no) 1993-04-21
LU85411A1 (fr) 1985-03-26
GB8414653D0 (en) 1984-07-11
JPS608222A (ja) 1985-01-17
SE8403110D0 (sv) 1984-06-08
FI83837C (fi) 1991-09-10
FI842274A0 (fi) 1984-06-06
AU569085B2 (en) 1988-01-21
BE899874A (fr) 1984-12-10
DE3421510A1 (de) 1984-12-20
IT8421331A0 (it) 1984-06-08
CH659945A5 (de) 1987-03-13
FI83837B (fi) 1991-05-31
OA07720A (fr) 1985-08-30
ES8707107A1 (es) 1987-07-16
GB2142534B (en) 1987-06-03
ATA189784A (de) 1991-07-15
IE841440L (en) 1984-12-09
DK163028C (da) 1992-06-09
DK283884A (da) 1984-12-10
GB2142534A (en) 1985-01-23
FR2547725B1 (fr) 1987-12-04
SE8403110L (sv) 1984-12-10
PT78713A (en) 1984-07-01

Similar Documents

Publication Publication Date Title
US5990100A (en) Composition and method for treatment of psoriasis
EP0391033B1 (en) Retinal, derivatives and their therapeutic use
US5422361A (en) Stable cream and lotion bases for lipophilic drug compositions
CA1078738A (en) Artificial skin darkening compositions
US5683713A (en) Pharmaceutical compositions for topical application
US5612327A (en) 1α,24-(OH)2 -cholecalciferol emulsion composition and method for treating psoriasis
KR20030011838A (ko) 유효 성분으로서 보효소 ｑ 를 함유하는 피부용 조성물
US4039664A (en) Topical griseofulvin composition and method
EP0473810B1 (en) Water and deprodone proprionate -containing external preparations
KR20000076280A (ko) 안정화된 미백 조성물 및 이의 제조 방법
US4034114A (en) Treatment of skin keratoses with retinal
US4661519A (en) Method for dermatological application
US5034420A (en) Compositions and method for stabilization of anthralin comprising the addition of an oil soluble antioxidant and an anionic surfactant
NZ208338A (en) Stabilisation of anthralin compositions by uncorporation of acid-stable anionic surfactant
AU674411B2 (en) Compositions for the treatment of inflammatory proliferative skin disease and their use
EP0740930B1 (en) Blood flow improver and cosmetic
KR20010073220A (ko) 혈관수축 활성이 개선된 플루티카손 로션
EP0332847B1 (en) Composition for preventing graying of the hair and restoring grayed hair to its natural color
JPS62142108A (ja) 育毛剤組成物
CA1256379A (en) Hair growth stimulating agents and their use
EP0712633B1 (en) Pharmaceutical compositions for topical application
GB2279567A (en) Topical 8-hydroxyquinoline compositions
CA2024642C (en) Water-containing external preparations
JPH0449216A (ja) メラニン抑制剤
Ramachandran et al. Influence of Nonionic Liposomal Composition on Topical Delivery of Peptide Drugs into Pilosebaceous Units: An in Vivo Study Using the Hamster Ear Model